| Bio:
| Christian Fletcher LifeBrite’s CEO believes that medicinal services are unfavorably influenced by the wrong clinical solution. Besides the expanding blunder in medical treatment services, the cost of healthcare treatment is rising at the same time. This is one of the major issues in the healthcare arena. To vanquish these issues, Christian Fletcher LifeBrite Lab is taking a transformative move towards value-based services. Value-based care is related to making patients care as the primary priority before anything and establishing all possible measures to provide the best treatment that facilitates faster recovery. They’re taking potential measures to upgrade the precision of lab results. This will ensure the precision in laboratory testing results. As of now, LifeBrite’s specialization incorporates urine drug testing, oral fluid drug testing, molecular pathology testing, respiratory pathogen testing, and blood chemistry testing. To guarantee the precision of reports and precision in treatment, they’re coordinating their laboratory procedures with cut-edge technologies. |
Three Years